Zobrazeno 1 - 10
of 234
pro vyhledávání: '"Christopher L, Hallemeier"'
Autor:
Christopher L. Hallemeier, MD, Kenneth W. Merrell, MD, Michelle A. Neben-Wittich, MD, Krishan R. Jethwa, MD, Harry H. Yoon, MD, Henry C. Pitot, MD, Shanda Blackmon, MD, K. Robert Shen, MD, Erik J. Tryggestad, PhD, Broc Giffey, CMD, Bret D. Kazemba, CMD, Jason K. Viehman, MS, William S. Harmsen, MS, Michael G. Haddock, MD
Publikováno v:
Advances in Radiation Oncology, Vol 9, Iss 8, Pp 101547- (2024)
Purpose: To evaluate the safety and efficacy of pencil beam scanning (PBS) proton radiation therapy (RT) in trimodality therapy for esophageal cancer. Methods and Materials: This prospective pilot study was planned to accrue 30 patients with locally
Externí odkaz:
https://doaj.org/article/e6c33f8f9d8a495f9155ba7f53fa443f
Autor:
Roman O. Kowalchuk, Grant M. Spears, Lindsay K. Morris, Dawn Owen, Harry H. Yoon, Krishan Jethwa, Michael D. Chuong, Matthew J. Ferris, Michael G. Haddock, Christopher L. Hallemeier, Dennis Wigle, Steven H. Lin, Kenneth W. Merrell
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Purpose/objectivePostoperative toxicity for esophageal cancer impacts patient quality of life and potentially overall survival (OS). We studied whether patient and toxicity parameters post-chemoradiation therapy predict for post-surgical cardiopulmon
Externí odkaz:
https://doaj.org/article/23f2d6302263427d9034c7e70803efb9
Autor:
Scott C. Lester, MD, Laura A. McGrath, MSN, Rachael M. Guenzel, DNP, Jenae C. Quinn, RTT, Carolyn J. Schultz, RN, T. Baron Bradley, CMD, Bret D. Kazemba, CMD, Shima Ito, MS, Christopher L. Hallemeier MD
Publikováno v:
International Journal of Particle Therapy, Vol 9, Iss 1, Pp 83-89 (2022)
Introduction Sexual dysfunction is a common toxicity and detrimental for the quality of life of women treated with chemoradiotherapy for anal cancer. Sexual dysfunction occurs because the vagina is closely approximated to the anal canal and typically
Externí odkaz:
https://doaj.org/article/a88ddd528c22478dbea8b5d08e039b0f
Autor:
Krupa S. Jani, Shou‐En Lu, James D. Murphy, Paul B. Romesser, Krishan R. Jethwa, Diana Li, Anupama Chundury, Abraham J. Wu, Lara Hathout, Christopher L. Hallemeier, Salma K. Jabbour
Publikováno v:
Cancer Medicine, Vol 10, Iss 11, Pp 3575-3583 (2021)
Abstract Background Increased risk of a second primary malignancy (SPM) before or after diagnosis of anal squamous cell carcinoma (ASCC) has been reported in a previous single‐institution study. We hypothesize that patients diagnosed with ASCC are
Externí odkaz:
https://doaj.org/article/96613193e64644aaafcb06d3af3560da
Autor:
Krishan R. Jethwa, Courtney N. Day, Harigopal Sandhyavenu, Karthik Gonuguntla, William S. Harmsen, William G. Breen, David M. Routman, Allison E. Garda, Joleen M. Hubbard, Thorvardur R. Halfdanarson, Michelle A. Neben-Wittich, Kenneth W. Merrell, Christopher L. Hallemeier, Michael G. Haddock
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 28, Iss , Pp 17-23 (2021)
Introduction: To report long-term efficacy and adverse events (AEs) associated with intensity modulated radiotherapy (IMRT) for patients with anal canal squamous cell carcinoma (ASCC). Materials and methods: This was a retrospective review of patient
Externí odkaz:
https://doaj.org/article/f80ea376971d4cb7a9c61ec994194be0
Autor:
Joseph A. Miccio, Wesley J. Talcott, Timil Patel, Henry S. Park, Michael Cecchini, Ronald R. Salem, Sajid A. Khan, Stacey Stein, Jeremy S. Kortmansky, Jill Lacy, Amol Narang, Joseph Herman, Salma K. Jabbour, Christopher L. Hallemeier, Kimberly Johung, Krishan R. Jethwa
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 27, Iss , Pp 15-23 (2021)
Purpose: Margin-negative (R0) resection is the only potentially curative treatment for patients with pancreatic ductal adenocarcinoma (PDAC). Pre-operative multi-agent chemotherapy alone (MAC) or MAC followed by pre-operative radiotherapy (MAC + RT)
Externí odkaz:
https://doaj.org/article/6cbac6a58777403cbed48d1acbe64aa0
Autor:
Jerry Yung-Lun Chin, MBBS, John A. Martin, MD, Christopher L. Hallemeier, MD, Michael G. Haddock, MD, Barham K. Abu Dayyeh, MD, MPH, Andrew C. Storm, MD, Mark Topazian, MD, Michael J. Levy, MD, Bret T. Petersen, MD, Vinay Chandrasekhara, MD
Publikováno v:
VideoGIE, Vol 6, Iss 2, Pp 62-66 (2021)
Externí odkaz:
https://doaj.org/article/49f5641da04043ae9c140c162ccf0573
Autor:
Elizabeth B. Jeans, MEd, MD, Krishan R. Jethwa, MD, William S. Harmsen, MS, Michelle Neben-Wittich, MD, Jonathan B. Ashman, MD, Kenneth W. Merrell, MD, Broc Giffey, CMD, Shima Ito, MS, Bret Kazemba, CMD, Chris Beltran, PhD, Michael G. Haddock, MD, Christopher L. Hallemeier, MD
Publikováno v:
Advances in Radiation Oncology, Vol 5, Iss 5, Pp 865-870 (2020)
Purpose: For treatment of rectal cancer, pencil beam scanning proton therapy (PBS-PT) may reduce radiation exposure to normal tissues compared with 3-dimensional conformal photon radiation therapy (3DCRT) or volumetric modulated arc photon radiation
Externí odkaz:
https://doaj.org/article/57dc62f2458743e29986b7f55f51e7f9
Autor:
Wei Deng, MD, Krishan R. Jethwa, MD, Karthik Gonuguntla, MD, Zhongxing Liao, MD, Harry H. Yoon, MD, Mariela Blum Murphy, MD, Michael G. Haddock, MD, Christopher L. Hallemeier, MD, Steven H. Lin, MD PhD
Publikováno v:
Advances in Radiation Oncology, Vol 5, Iss 5, Pp 951-958 (2020)
Purpose: To evaluate the safety and efficacy of definitive chemoradiotherapy (CRT) for patients with clinical T1N0M0 esophageal adenocarcinoma. Methods and Materials: This was a retrospective study of patients with clinical T1N0 adenocarcinoma of the
Externí odkaz:
https://doaj.org/article/c49f54d9fa6b428ab649943d058b8c26
Autor:
Ronik S. Bhangoo, MD, Todd A. DeWees, PhD, Nathan Y. Yu, MD, Julia X. Ding, BA, Chenbin Liu, PhD, Michael A. Golafshar, MS, William G. Rule, MD, Sujay A. Vora, MD, Helen J. Ross, MD, Daniel H. Ahn, DO, Staci E. Beamer, MD, Dawn E. Jaroszewski, MD, Christopher L. Hallemeier, MD, Wei Liu, PhD, Jonathan B. Ashman, MD, PhD, Terence T. Sio, MD, MS
Publikováno v:
Advances in Radiation Oncology, Vol 5, Iss 5, Pp 871-879 (2020)
Purpose: Intensity modulated proton beam radiation therapy (IMPT) has a clinically significant dosimetric advantage over intensity modulated photon radiation therapy (IMRT) for the treatment of patients with esophageal cancer, particularly for sparin
Externí odkaz:
https://doaj.org/article/cbf592034c154618b3e7edb956adcff3